Skip to main content
. Author manuscript; available in PMC: 2014 Mar 31.
Published in final edited form as: Bone Marrow Transplant. 2011 Dec 5;47(8):1056–1060. doi: 10.1038/bmt.2011.236

Figure 3. Cumulative incidence of sustained donor neutrophil engraftment after myeloablative DCBT according to the total donor chimerism in the day 21 BM biopsy in all patients (3A) and in patients not engrafted at the time the BM analysis was performed (3B).

Figure 3

Figure 3

Total donor chimerism had a highly significant association with engraftment (3A) and was the most critical factor predicting subsequent engraftment (3B).